
Theratechnologies THTX
Geschäftsbericht 2024
hinzugefügt 21.02.2026
Theratechnologies DPO 2011-2026 | THTX
DPO Jährlich Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 279 | 171 | 285 | 75.5 | 50.4 | - | 31 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 31 K | 50.4 | 5.31 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
405 | $ 0.79 | -6.17 % | $ 4.31 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
235 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
529 | $ 164.05 | -1.4 % | $ 8.16 B | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
BridgeBio Pharma
BBIO
|
399 | $ 64.53 | -1.48 % | $ 12.4 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Avid Bioservices
CDMO
|
62.3 | - | - | $ 789 M | ||
|
BioMarin Pharmaceutical
BMRN
|
245 | $ 58.53 | -2.03 % | $ 11.2 B | ||
|
Caladrius Biosciences
CLBS
|
51.2 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
236 | - | -7.23 % | $ 13 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
CTI BioPharma Corp.
CTIC
|
306 | - | - | $ 1.2 B | ||
|
Cyclacel Pharmaceuticals
CYCC
|
1.79 K | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.79 K | - | -4.36 % | $ 27 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.2 K | - | - | $ 2.18 B | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Codexis
CDXS
|
98.4 | $ 0.98 | -3.92 % | $ 71.9 M | ||
|
Certara
CERT
|
7.85 | $ 7.24 | 2.7 % | $ 1.16 B | ||
|
Evofem Biosciences
EVFM
|
897 | - | 7.55 % | $ 38.1 M | ||
|
Coherus BioSciences
CHRS
|
53.7 | $ 1.65 | - | $ 155 M |